Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan

Cancer Genetics and Cytogenetics

Volumn 149, Issue 1, 2004, Pages 77-80

  Matsuo, Keitaro ^a   Hamajima, Nobuyuki ^b   Suzuki, Ritsuro ^a   Andoh, Manabu ^a   Nakamura, Shigeo ^a   Seto, Masao ^a   Morishima, Yasuo ^a   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA BASE; GLUTAMINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; FEMALE; FOLLICULAR LYMPHOMA; GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; LARGE CELL LYMPHOMA; LOGISTIC REGRESSION ANALYSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; XRCC1 GENE;

EID: 0842302963     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00296-6     Document Type: Article

References (27)

1. Kubota Y., Nash R.A., Klungland A., Schar P., Barnes D.E., Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J. 15:1996;6662-6670.
2. Caldecott K.W., McKeown C.K., Tucker J.D., Ljungquist S., Thompson L.H. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol. 14:1994;68-76.
3. Masson M., Niedergang C., Schreiber V., Muller S. Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 18:1998;3563-3571.
4. Shen M.R., Jones I.M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 58:1998;604-608.
5. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59:1999;2557-2561.
6. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D., Mark E.J., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 21:2000;965-971.
7. Lei Y.C., Hwang S.J., Chang C.C., Kuo H.W., Luo J.C., Chang M.J., Cheng T.J. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res. 519:2002;93-101.
8. Seedhouse C., Bainton R., Lewis M., Harding A., Russell N., Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood. 100:2002;3761-3766.
9. Matsuo K., Suzuki R., Hamajima N., Ogura M., Kagami Y., Taji H., Kondoh E., Maeda S., Asakura S., Kaba S., Nakamura S., Seto M., Morishima Y., Tajima K. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood. 97:2001;3205-3209.
10. Hishida A., Matsuo K., Hamajima N., Ito H., Ogura M., Kagami Y., Taji H., Morishima Y., Emi N., Tajima K. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica. 88:2003;159-166.
11. Matsuo K., Hamajima N., Suzuki R., Nakamura S., Seto M., Morishima Y., Tajima K. No substantial difference in genotype frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Haematologica. 86:2001;602-608.
12. Hamajima N., Matsuo K., Saito T., Hirose K., Inoue M., Takezaki T., Kuroishi T., Tajima K. Gene-environment interaction and polymorphism studies of cancer risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev. 2:2001;99-108.
13. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res. 91:2000;865-868.
14. Sturgis E.M., Castillo E.J., Li L., Zheng R., Eicher S.A., Clayman G.L., Strom S.S., Spitz M.R., Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis. 20:1999;2125-2129.
15. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 89:1997;3909-3918.
16. Xing D., Qi J., Miao X., Lu W., Tan W., Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer. 100:2002;600-605.
17. Chen S., Tang D., Xue K., Xu L., Ma G., Hsu Y., Cho S.S. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis. 23:2002;1321-1325.
18. Matullo G., Guarrera S., Carturan S., Peluso M., Malaveille C., Davico L., Piazza A., Vineis P. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer. 92:2001;562-567.
19. Duell E.J., Holly E.A., Bracci P.M., Wiencke J.K., Kelsey K.T. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res. 62:2002;4630-4636.
20. van Gils C.H., Bostick R.M., Stern M.C., Taylor J.A. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev. 11:2002;1279-1284.
21. Duell E.J., Millikan R.C., Pittman G.S., Winkel S., Lunn R.M., Tse C.K., Eaton A., Mohrenweiser H.W., Newman B., Bell D.A. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 10:2001;217-222.
22. Divine K.K., Gilliland F.D., Crowell R.E., Stidley C.A., Bocklage T.J., Cook D.L., Belinsky S.A. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res. 461:2001;273-278.
23. David-Beabes G.L., London S.J. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and caucasians. Lung Cancer. 34:2001;333-339.
24. Shen H., Xu Y., Qian Y., Yu R., Qin Y., Zhou L., Wang X., Spitz M.R., Wei Q. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 88:2000;601-606.
25. Bonassi S., Abbondandolo A., Camurri L., Dal Pra L., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Padovani P., Sbrana I., Vecchio D., Puntoni R. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet. 79:1995;133-135.
26. Hagmar L., Brogger A., Hansteen I.L., Heim S., Hogstedt B., Knudsen L., Lambert B., Linnainmaa K., Mitelman F., Nordenson I. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 54:1994;2919-2922.
27. Bonassi S., Hagmar L., Stromberg U., Montagud A.H., Tinnerberg H., Forni A., Heikkila P., Wanders S., Wilhardt P., Hansteen I.L., Knudsen L.E., Norppa H. European Study Group on Cytogenetic Biomarkers and Health. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res. 60:2000;1619-1625.